JUNS jupiterneurosciences.com Soliqlar to‘langandan keyingi foyda

Jupiter Neurosciences, Inc. (JUNS) kompaniyasining rasmiy ramzlari

Jupiter Neurosciences Inc (JUNS) neyrodegeneratsiya sohasida shifokorlarning ishonchini ta'minlovchi kuchli ilmiy asosga ega, buni kompaniyaning hozirda taxminan -0.01 miqdorini tashkil etuvchi marjinal daromadi tasdiqlaydi. Strategiya ishlab chiqarish va logistika bo'yicha uchinchi tomon pudratchilari orqali jarayonlarni optimallashtirish bilan to'ldirilsa-da, yagona molekulaga e'tibor qaratilgani dori vositasining tijoratga chiqarilishidan oldin aktiv uchun yuqori binar xavfni yuzaga keltiradi.

Jupiter Neurosciences, Inc. (JUNS) Kompaniyaning sof foydasi: 04.12.2024 - 30.10.2026 davri uchun

Jupiter Neurosciences (JUNS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi jupiterneurosciences.com|JUNS - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Jupiter Neurosciences Inc|JUNS - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Jupiter Neurosciences|JUNS - Kompaniyaning balans qiymati|Sof aktivlarga nisbatan bozor kapitallashuvi jupiterneurosciences.com|JUNS - Kompaniyaning umumiy aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Jupiter Neurosciences Inc|JUNS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati Jupiter Neurosciences, Inc.|JUNS - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Jupiter Neurosciences Inc|JUNS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Jupiter Neurosciences|Oraliq qoplash koeffitsiyenti jupiterneurosciences.com
- foyda va bozor multiplikatorlari tafsilotlari:
JUNS - Kompaniyaning sof foydasi
Fundamental baholash:JUNS jupiterneurosciences.com
jupiterneurosciences.com seriyali mahsuloti

Ushbu ko'rsatkich bozor tebranishlaridan tozalangan sof kunlik moliyaviy natijani o'lchaydi, bu esa investorlarga rasmiy hisobotlar e'lon qilinishidan oldin yashirin tizimli risklarni aniqlash imkonini beradi. Jupiter Neurosciences Inc (JUNS) kompaniyasining yakuniy moliyaviy natijalarini tahlil qilish orqali, MKS kasalliklariga qarshi kurashish uchun kichik molekulyar platformaga kiritilgan investitsiyalarning samaradorligini baholash mumkin, bunda ushbu metrikaning barqarorligi tijoriy farmatsevtika bozorini egallash sur'ati va kapital likvidligini belgilaydi.

Asosiy raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|RGC (regencellbioscience.com) - Soliqlar to‘langandan keyingi foyda|Sof daromad AXSM (Axsome Therapeutics, Inc.)|Sof foyda ACADIA Pharma (ACAD)|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|VKTX (Viking Therapeutics Corp) - Soliqdan keyingi foyda|Supernus Pharmaceuticals - Sof foyda|Sof moliyaviy natija catalystpharma.com CPRX|DNLI (Denali Therapeutics Inc.) - Sof daromad|HRMY: Soliqlar to‘langandan keyingi foyda|BHVN (Biohaven Pharmaceutical) - Sof foyda|Kompaniyaning sof daromadi Amylyx Corp AMLX|Kompaniyaning sof foydasi Trevi Therapeutics (TRVI)|PRAX (praxismedicines.com) - Yakuniy foyda|Anavex Life Sciences Corp. - Sof daromad|Yakuniy foyda CBLL|PRTA - Kompaniyaning sof foydasi|ALEC (Alector, Inc.) - Kompaniya foydasi|ANNX: Sof foyda|Kompaniyaning sof daromadi Omeros (OMER)|Sof daromad NGNE|Sof foyda AC Immune S.A.|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|NMRA (Neumora Corp) - Yakuniy foyda|Kompaniyaning sof foydasi Scilex Holding Company SCLX|tevogen.com (TVGN) - Kompaniyaning sof daromadi|ACOG - Kompaniyaning sof foydasi|Sof moliyaviy natija cogrx.com CGTX|IKT: Sof foyda|Sof daromad Cassava Pharma|ASRT (Assertio Holdings) - Sof foyda|Coya (COYA) - Sof moliyaviy natija|Sof foyda VTGN|OVID - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Acumen Pharma ABOS|CRVO: Kompaniya foydasi|Alterity Therapeutics Ltd - Sof foyda|Clene Inc. (CLNN) - Sof daromad|PEPG: Sof foyda|Kompaniyaning sof daromadi Relmada Therapeutics Inc (RLMD)|Kompaniyaning sof foydasi Annovis Bio Corp|Grace Tx (GRCE) - Sof moliyaviy natija|Sof daromad AIFF (Firefly Neuroscience, Inc)|KLTO (anewmeds.com) - Yakuniy foyda|Sof foyda NRSN (NeuroSense Therapeutics Ltd.)|Sof moliyaviy natija Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA - Kompaniyaning sof foydasi|NRXS (NeurAxis Inc) - Kompaniya foydasi|HSDT: Sof foyda|Sof daromad Passage Bio|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|NERV (Minerva Neurosciences Inc) - Soliqlar to‘langandan keyingi foyda|Sof daromad ATHA (Athira)|Sof foyda Addex (ADXN)|Kompaniyaning sof foydasi Alzamend Neuro ALZN|CYCN: Kompaniya foydasi|PTIX - Kompaniyaning sof foydasi|Sof moliyaviy natija Pasithea Therapeutics KTTA|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Kompaniya foydasi ATXI|BCLI (Brainstorm Cell) - Sof foyda|Kompaniyaning sof daromadi caratherapeutics.com CARA|Sof daromad CHRO (Chromocell Therapeutics Corp.)|Sof foyda eliemtx.com (ELYM)|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|Yakuniy foyda LBPH|MRNS - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi nkgenbiotech.com|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|SAGE: Soliqlar to‘langandan keyingi foyda|Sof daromad SNPX|Sof foyda Trevena Inc|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|WENA: Soliqdan keyingi foyda|Sof foyda CERE (Cerevel Therapeutics, Inc.)